Heterogeneity of novel APOER2 isoforms specific to Alzheimer’s disease impact cellular and synaptic states

Apolipoprotein receptor 2 (APOER2) is an alternatively spliced transmembrane receptor that binds the neuroprotective ligand Reelin and Alzheimer’s disease (AD) related risk factor, APOE. Splicing of single exons in mouse Apoer2 regulates neuronal function and synaptic plasticity. However, the splicing landscape and function of human APOER2 isoforms in physiological and AD conditions remains unclear. Here, we identified over 200 unique human APOER2 isoforms in the parietal cortex and hippocampus with 151 isoforms common between the two brain regions. In addition, we identified region- and AD-specific APOER2 isoforms suggesting APOER2 splicing is spatially regulated and altered in AD. We tested whether the AD-specific APOER2 transcripts have distinct functional properties, and demonstrated AD-specific APOER2 variants have altered cell surface expression, APOE-mediated receptor processing and synaptic changes which could contribute to neuronal dysfunction associated with AD pathogenesis.

[1]  A. Ho,et al.  Human APOER2 Isoforms Have Differential Cleavage Events and Synaptic Properties , 2022, The Journal of Neuroscience.

[2]  Adam T. Labadorf,et al.  Single molecule, long-read Apoer2 sequencing identifies conserved and species-specific splicing patterns. , 2022, Genomics.

[3]  Mireya Plass,et al.  RNA Dynamics in Alzheimer’s Disease , 2021, Molecules.

[4]  M. Clark,et al.  Isoform Age - Splice Isoform Profiling Using Long-Read Technologies , 2021, Frontiers in Molecular Biosciences.

[5]  S. Farris,et al.  Spatiotemporal Regulation of Transcript Isoform Expression in the Hippocampus , 2021, Frontiers in Molecular Neuroscience.

[6]  J. Weuve,et al.  Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060) , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[7]  Stephen R. Williams,et al.  A spatially resolved brain region- and cell type-specific isoform atlas of the postnatal mouse brain , 2021, Nature Communications.

[8]  Astrid Gall,et al.  Ensembl 2021 , 2020, Nucleic Acids Res..

[9]  Matthew E. Ritchie,et al.  Comprehensive characterization of single cell full-length isoforms in human and mouse with long-read sequencing , 2020, bioRxiv.

[10]  E. Lau,et al.  Determining Alternative Protein Isoform Expression Using RNA Sequencing and Mass Spectrometry , 2020, STAR protocols.

[11]  A. Ho,et al.  ApoER2: Functional Tuning Through Splicing , 2020, Frontiers in Molecular Neuroscience.

[12]  J. N. Kay,et al.  Comprehensive identification of mRNA isoforms reveals the diversity of neural cell-surface molecules with roles in retinal development and disease , 2020, Nature Communications.

[13]  Matthew R. Gazzara,et al.  Deep profiling and custom databases improve detection of proteoforms generated by alternative splicing , 2019, Genome research.

[14]  J. Rapoport,et al.  Neuronal impact of patient-specific aberrant NRXN1α splicing , 2019, Nature Genetics.

[15]  Bin Zhang,et al.  Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation , 2019, bioRxiv.

[16]  Michael D. Greicius,et al.  A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward , 2019, Neuron.

[17]  Bin Zhang,et al.  Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer’s disease susceptibility , 2018, Nature Genetics.

[18]  P. Dlugosz,et al.  The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor , 2018, International journal of molecular sciences.

[19]  H. Hayashi,et al.  Furin inhibitor protects against neuronal cell death induced by activated NMDA receptors , 2018, Scientific Reports.

[20]  Daniel C. Liebler,et al.  Detection of Proteome Diversity Resulted from Alternative Splicing is Limited by Trypsin Cleavage Specificity* , 2017, Molecular & Cellular Proteomics.

[21]  Lennart Martens,et al.  1 SQANTI : extensive characterization of long read transcript sequences for quality control in 1 full-length transcriptome identification and quantification 2 3 , 2017 .

[22]  D. Bennett,et al.  Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides , 2016, EMBO molecular medicine.

[23]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[24]  M. Rosenfeld,et al.  LRP8-Reelin-Regulated Neuronal Enhancer Signature Underlying Learning and Memory Formation , 2015, Neuron.

[25]  R. Hammer,et al.  Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning , 2014, Science Signaling.

[26]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[27]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[28]  Thomas C. Südhof,et al.  Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing , 2014, Proceedings of the National Academy of Sciences.

[29]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[30]  Jenny Wong,et al.  Altered Expression of RNA Splicing Proteins in Alzheimer's Disease Patients: Evidence from Two Microarray Studies , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[31]  Guojun Bu,et al.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[32]  Tomaž Curk,et al.  Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. , 2011, Genome research.

[33]  M. Wilkins,et al.  Whole Transcriptome Sequencing Reveals Gene Expression and Splicing Differences in Brain Regions Affected by Alzheimer's Disease , 2011, PloS one.

[34]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[35]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[36]  Jennifer A. Siepen,et al.  Investigating protein isoforms via proteomics: A feasibility study , 2010, Proteomics.

[37]  Guojun Bu,et al.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.

[38]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[39]  Jordan J. N. Tang,et al.  Apolipoprotein Receptor 2 and X11α/β Mediate Apolipoprotein E-Induced Endocytosis of Amyloid-β Precursor Protein and β-Secretase, Leading to Amyloid-β Production , 2007, The Journal of Neuroscience.

[40]  M. Frotscher,et al.  Modulation of Synaptic Plasticity and Memory by Reelin Involves Differential Splicing of the Lipoprotein Receptor Apoer2 , 2005, Neuron.

[41]  G. Rebeck,et al.  Regulation of ApoE receptor proteolysis by ligand binding. , 2005, Brain research. Molecular brain research.

[42]  H. Bock,et al.  Differential Glycosylation Regulates Processing of Lipoprotein Receptors by γ-Secretase* , 2003, Journal of Biological Chemistry.

[43]  J. Morrison,et al.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.

[44]  J. Sweatt,et al.  Reelin and ApoE Receptors Cooperate to Enhance Hippocampal Synaptic Plasticity and Learning* , 2002, The Journal of Biological Chemistry.

[45]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[46]  M. Trabucchi,et al.  Clinical aspects of Alzheimer’s disease , 2001, Aging.

[47]  B. Hyman,et al.  Expression and alternate splicing of apolipoprotein E receptor 2 in brain , 1999, Neuroscience.

[48]  T. Fujita,et al.  Exon/Intron Organization, Chromosome Localization, Alternative Splicing, and Transcription Units of the Human Apolipoprotein E Receptor 2 Gene* , 1997, The Journal of Biological Chemistry.

[49]  K. Goto,et al.  Human Apolipoprotein E Receptor 2 A NOVEL LIPOPROTEIN RECEPTOR OF THE LOW DENSITY LIPOPROTEIN RECEPTOR FAMILY PREDOMINANTLY EXPRESSED IN BRAIN* , 1996 .

[50]  T. Willnow,et al.  The low-density-lipoprotein receptor-related protein (LRP) is processed by furin in vivo and in vitro. , 1996, The Biochemical journal.

[51]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[52]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.